Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low dose calcineurin inhibitors

被引：0
|
作者：
Dubay, Derek [1 ]
Lilly, Leslie [1 ]
Smith, Robert [1 ]
Levy, Gory A. [1 ]
Therapondos, George [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, MultiOrgan Transplant Program, Toronto, ON M4X 1K9, Canada
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：495A / 495A
页数：1
相关论文
共 50 条
  • [1] Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens
    Dubay, Derek
    Smith, Rob J.
    Qiu, Kenneth G.
    Levy, Gary A.
    Lilly, Leslie
    Therapondos, George
    [J]. LIVER TRANSPLANTATION, 2008, 14 (05) : 651 - 659
  • [2] Sirolimus Monotherapy Effectiveness in Liver Transplant Recipients With Renal Dysfunction Due to Calcineurin Inhibitors
    Di Benedetto, Fabrizio
    Di Sandro, Stefano
    De Ruvo, Nicola
    Spaggiari, Mario
    Montalti, Roberto
    Ballarin, Roberto
    Cappelli, Gianni
    Gerunda, Giorgio E.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (03) : 280 - 286
  • [3] Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.
    Mies, Sergio
    Beduschi, Thiago
    Silva, Vinicius M. R.
    Mies, Ana Olga N. G. F.
    Della Guardia, Bianca
    Baia, Carlos E. S.
    de Almeida, Marcio D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S189 - S189
  • [4] Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients
    Nair, S
    Eason, J
    Loss, G
    [J]. LIVER TRANSPLANTATION, 2003, 9 (02) : 126 - 129
  • [5] Conversion from calcineurin inhibitors (CNIs) to sirolimus (SRL) immunosuppression is beneficial in liver transplant (LT) recipients with renal dysfunction (RD).
    Cejas, Nora
    Casciato, Paola
    Descalzi, Valeria
    Galdame, Omar
    Gadano, Adrian
    Imventarza, Oscar
    Villamil, Federico
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S113 - S113
  • [6] Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction
    El-Hamamsy, I.
    Stevens, L. M.
    White, M.
    Perrault, L. P.
    Pellerin, M.
    Carrier, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S120 - S121
  • [7] The Efficacy and Limitations of Sirolimus Conversion in Liver Transplant Patients Who Develop Renal Dysfunction on Calcineurin Inhibitors
    Patrick Lam
    Atsushi Yoshida
    Kimberly Brown
    Marwan Abouljoud
    Iman Bajjoka
    Fadi Dagher
    Dilip K. Moonka
    [J]. Digestive Diseases and Sciences, 2004, 49 : 1029 - 1035
  • [8] The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors
    Lam, P
    Yoshida, A
    Brown, K
    Abouljoud, M
    Bajjoka, I
    Dagher, F
    Moonka, DK
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1029 - 1035
  • [9] Pharmacogenetics in immunosuppressants: impact on dose requirement of calcineurin inhibitors in renal and liver pediatric transplant recipients
    Quteineh, Lina
    Verstuyft, Celine
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (05) : 601 - 607
  • [10] Effects of Conversion From Calcineurin Inhibitors to Sirolimus or Everolimus on Renal Function and Possible Mechanisms in Liver Transplant Recipients
    Tsai, Kai-Fan
    Li, Lung-Chih
    Hsu, Chien-Ning
    Lin, Chih-Che
    Lin, Yu-Hung
    Cheng, Yu-Fan
    Wang, Chih-Chi
    Chen, Chao-Long
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 326 - 334
12345